Premium Essay

Obesiity

In:

Submitted By GBnana2
Words 1813
Pages 8
Obesity: What can we do? Tracy Garrett Sep. 29, 2014

Obesity: What can we do? By: Tracy Garrett Professor Pearson ENG 122 September 29, 2014

Obesity: What can we do?

Thesis
Obesity is a medical condition where our body forms excess fat to the point that it is harmful to our bodies, young and old. Doctors have said that obesity is a terrible disease, like diabetes and high blood pressure. In this case, obesity has long term problems on our health. Obesity is the second leading cause of deaths that can be preventable, it not only affects our children, but adults are affected as well. As adults it is sometimes harder to get it under control, but we can do it and as far as our children we are the ones responsible for making sure that they stay healthy.

Obesity: What can we do? Tg. Pp.2
Obesity is a very serious disease that people tend to look over, thinking that a person that is that big eats whatever they want when they want and their children are going to take after them. But what people don’t know is that behind every obese adult or child lies problems that will affect them for life and if it is not gotten under control then more serious outcomes will arise. As our young children get older the effects of obesity will shorten the length of their lives. Today in children, between the ages of two and five have excess body fat and already on their way to being obese. This is dangerous of childhood obesity rates. Several factors can influence the risk of obesity therefore addressing the problem, trends and helping preventative measures can help in slowing down obesity in children and adults. There are many groups of people and other measures that can help in stabilizing the health of people that the will grow healthy important early detection to the risk of

Similar Documents

Premium Essay

Merck Decision Tree

...Tree Although a decision analysis would recommend that Merck not commit to the proposal, the company's balance sheet shows that it has significant assets to support a loss. The projected values of earning for depression and dual indications seem to be worth the risk. Weightloss does not. Not Effective 15.0% 0 Phase III: Long Term Efficacy Testing #NAME? 25.0% 0 #NAME? #NAME? Obesity Don't Test #NAME? 0 #NAME? #NAME? Dual Indications 50.0% -400,000,000 #NAME? #NAME? #NAME? #NAME? Depression: effective #NAME? 0 Indications #NAME? 15.0% -250,000,000 Conduct Depression: not effective 10.0% 0 #NAME? #NAME? #NAME? #NAME? #NAME? #NAME? #NAME? #NAME? Obesity: effective 5.0% -100,000,000 Obesiity: not effective 10.0% 0 Complete Failure 70.0% -$500,000,000.00 Phase 4: Additional Trials #NAME? 10.0% 0 Effective Do not conduct #NAME? 0 #NAME? #NAME? 0 #NAME? #NAME? Test Not Effective 5.0% 0 Phase III: Long Term Efficacy Testing #NAME? 30.0% 0 #NAME? #NAME? Both Don't Test 70.0% 0 #NAME? #NAME? #NAME? 0 #NAME? #NAME? Neither 60.0% 0 Phase II Efficacy Testing #NAME? Don't Test #NAME? -$30,000,000.00 Phase 1: Efficacy testing #NAME? #NAME? 0 #NAME? #NAME? Pass Test Fail Preclinical Analysis Test #NAME? 40.0% 0 #NAME? #NAME? Davanrik Licensing Decision Tree Cost Testing costs Launch Costs Total Projected value Net Gain Depression only $520,000,000...

Words: 354 - Pages: 2